PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.06%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-28.41%
Negative EBIT growth while 3141.T is at 55.70%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-36.83%
Negative operating income growth while 3141.T is at 3.61%. Joel Greenblatt would press for urgent turnaround measures.
-31.02%
Negative net income growth while 3141.T stands at 72.67%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-29.31%
Negative EPS growth while 3141.T is at 72.53%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-29.31%
Negative diluted EPS growth while 3141.T is at 72.53%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3141.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-394.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2595.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
11.78%
10Y revenue/share CAGR under 50% of 3141.T's 42.26%. Michael Burry would suspect a lasting competitive disadvantage.
11.78%
5Y revenue/share CAGR under 50% of 3141.T's 42.26%. Michael Burry would suspect a significant competitive gap or product weakness.
11.78%
3Y revenue/share CAGR under 50% of 3141.T's 42.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-195.64%
Negative 10Y OCF/share CAGR while 3141.T stands at 108.12%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-195.64%
Negative 5Y OCF/share CAGR while 3141.T is at 108.12%. Joel Greenblatt would question the firm’s operational model or cost structure.
-195.64%
Negative 3Y OCF/share CAGR while 3141.T stands at 108.12%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
34.67%
Below 50% of 3141.T's 76.99%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
34.67%
Below 50% of 3141.T's 76.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
34.67%
Below 50% of 3141.T's 76.99%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
22.00%
Equity/share CAGR of 22.00% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
22.00%
Equity/share CAGR of 22.00% while 3141.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
22.00%
Equity/share CAGR of 22.00% while 3141.T is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.